Resources

The User Manual includes detailed descriptions of the NativeSkin^® model, available formats, and a step-by-step guide for kit use.

Discover VaxSkin’s features and its real-world applications with this video presented by our CSO at the World Vaccine Congress Europe.

Vaccine DevelopmentGenerate human immunological insights with a comprehensive solution for vaccine development Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable naturalRead more

Accelerating Vaccine Development with TranscriptomicsThe landscape of vaccine development is undergoing a significant transformation with the advent of transcriptomic approaches. These technologies offer unprecedented insights into the complexities of the immune system, enabling the creation of more effective and targeted vaccines. Understanding Transcriptomics In the cutting-edge field of vaccine development, transcriptomics stands out as a revolutionary approach, offering unprecedented insightsRead more

Injection-Site PainWhich factors influence pain upon subcutaneous injection?Biologics such as vaccines, insulin, monoclonal antibodies, etc., that are now widely developed need to be administered parenterally. While the intravenous (IV) route has historically been the most widely used,  the subcutaneous (SC) route is now accepted and presented as safe and effective, whether in the context of chronic disease or in palliativeRead more

Immunogenicity SeriesPart 4 - Evaluating and managing immunogenicity for vaccinesImmunogenicity is crucial in vaccine development, it represents the capacity of a substance, such as a vaccine, to elicit an immune response. This reaction can be beneficial, providing protection against diseases, or detrimental, resulting in adverse effects. In vaccine development, the goal is to trigger on-target immunogenicity to activate the immuneRead more